Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoetis Equip® Artervac vaccine stock to expire on 13 Dec 2018
Current vaccine stock will expire on 13 December 2018.

Further stock not expected to arrive before February 2019

Zoetis have announced that stock of their Equine Viral Arteritis vaccine, Equip Artervac, is due to expire on 13 December 2018. Further stock is not expected to arrive before February 2019.

Equip Artervac is specified for the active immunisation for horses against equine arteritis virus (EVA) to reduce the clinical signs and shedding of virus in nasal secretions following infection.

In the UK, EVA is a notifiable disease. The last confirmed case in the UK was in 2012.

Zoetis is working hard to resolve the situation and apologises for any inconvenience.

Those concerned are encouraged to contact their Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.

Become a member or log in to add this story to your CPD history

Public urged to provide homes for swifts

News Story 1
 The RSPB is calling on the public to help provide new homes for swifts, as figures show the birds' numbers have fallen to less than half what they were 20 years ago.

Swifts arrive in the UK late April-May and can spend up to three months in the country. The RSPB attributes the birds’ decline to modern buildings, which lack the nooks and crannies they need to build nests.

While some house builders have agreed to integrate swift homes into new buildings, the RSPB believes more can be done to help this incredible bird. 'Just, 1,000 additional new nest boxes could make a difference’, the charity said.  

Click here for more...
News Shorts
Detection time for omeprazole reduced to 48 hours in racehorses

The British Horseracing Authority (BHA) has announced that the detection time for omeprazole has been reduced from 72 hours to 48 hours. This is effective from 1 February 2019.

Omeprazole can be prescribed for the management of gastric ulcers in racehorses; however, studies have recently become available that show no direct effect of omeprazole on performance.

Tim Morris, the Authority’s Director of Equine Science and Welfare, commented: “Medication control in horse racing is essential to allow treatment for good welfare but also to ensure fair racing by medication withdrawal before racing. Trainers have asked for more information, especially on anti-ulcer medications, and we have used existing information to make a harmonised detection time for omeprazole available as soon as we could.”